Recall Weekly
Moderate riskFDA DrugClass II

Victory Medical Center tirzepatide recalled over processing controls

Victory Medical Center Pharmacy in Austin, Texas, is recalling 50 vials of compounded tirzepatide/L-carnitine injection (30/100 mg/mL, 2 mL). The FDA cites a lack of processing controls in how the product was made. No injuries have been reported.

From the FDA notice · Read the official notice ↗ · All Victory Medical Center Pharmacy recalls

What to do

  1. Check whether your vial is lot 2060378 with an expiration date of 11/4/2026.
  2. If it matches, do not use it. Contact Victory Medical Center Pharmacy or your prescriber about next steps.
Official notice ↗

Is yours affected?

Compare your label or packaging with the recalled product.

Product
TIRZEPATIDE/L-CARNITINE 30/100MG/ML (MDV) **2ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas
Sold in
CO, FL, TX
Made for
Adults (0 months and older)

This recall covers 42 products — see all of them.

Details

Units affected
50 vials
Illnesses reported
None reported
Manufactured in
4303 Victory Dr, Austin, Texas, United States
Classification
Class II
Recall number
D-0153-2027

In the FDA's words

Description
TIRZEPATIDE/L-CARNITINE 30/100MG/ML (MDV) **2ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas Lack of Processing Controls Lot, expiry: Lot 2060378 , exp 11/4/2026 Distribution: CO, FL, TX Affected quantity: 50 vials
Hazard
Lack of Processing Controls

42 products in this recall

Victory Medical Center injectables recalled for lack of processing controls

Victory Medical Center Pharmacy is recalling 42 injectable vial products because of a lack of processing controls. The products were distributed in Colorado, Florida, and Texas, and include alpha lipoic acid, ascorbic acid, B complex, BPC-157, CJC-1295, dexamethasone, methylcobalamin, and NAD+, among others. No injuries have been reported.

The agency lists each product separately. Check every one you might have.

More from Victory Medical Center Pharmacy

See all

Related topics

SterilityDrugsCOFLTXMore from FDA Drug